全文获取类型
收费全文 | 27224篇 |
免费 | 1875篇 |
国内免费 | 1208篇 |
专业分类
耳鼻咽喉 | 37篇 |
儿科学 | 547篇 |
妇产科学 | 235篇 |
基础医学 | 1793篇 |
口腔科学 | 59篇 |
临床医学 | 3655篇 |
内科学 | 6826篇 |
皮肤病学 | 72篇 |
神经病学 | 896篇 |
特种医学 | 2403篇 |
外国民族医学 | 8篇 |
外科学 | 3915篇 |
综合类 | 4020篇 |
现状与发展 | 2篇 |
预防医学 | 1007篇 |
眼科学 | 108篇 |
药学 | 2684篇 |
15篇 | |
中国医学 | 632篇 |
肿瘤学 | 1393篇 |
出版年
2024年 | 34篇 |
2023年 | 369篇 |
2022年 | 703篇 |
2021年 | 913篇 |
2020年 | 905篇 |
2019年 | 855篇 |
2018年 | 854篇 |
2017年 | 806篇 |
2016年 | 804篇 |
2015年 | 938篇 |
2014年 | 1694篇 |
2013年 | 1822篇 |
2012年 | 1558篇 |
2011年 | 1768篇 |
2010年 | 1477篇 |
2009年 | 1491篇 |
2008年 | 1420篇 |
2007年 | 1507篇 |
2006年 | 1327篇 |
2005年 | 1199篇 |
2004年 | 911篇 |
2003年 | 769篇 |
2002年 | 675篇 |
2001年 | 657篇 |
2000年 | 506篇 |
1999年 | 472篇 |
1998年 | 397篇 |
1997年 | 330篇 |
1996年 | 325篇 |
1995年 | 332篇 |
1994年 | 322篇 |
1993年 | 237篇 |
1992年 | 209篇 |
1991年 | 183篇 |
1990年 | 150篇 |
1989年 | 154篇 |
1988年 | 125篇 |
1987年 | 107篇 |
1986年 | 121篇 |
1985年 | 139篇 |
1984年 | 124篇 |
1983年 | 61篇 |
1982年 | 105篇 |
1981年 | 86篇 |
1980年 | 77篇 |
1979年 | 61篇 |
1978年 | 59篇 |
1977年 | 40篇 |
1976年 | 39篇 |
1974年 | 21篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
Timothy M. Pawlik Kelly Olino Ana Luiza Gleisner Michael Torbenson Richard Schulick Michael A. Choti 《Journal of gastrointestinal surgery》2007,11(7):860-868
Some investigators have suggested that preoperative chemotherapy for hepatic colorectal metastases may cause hepatic injury
and increase perioperative morbidity and mortality. The objective of the current study was to examine whether treatment with
preoperative chemotherapy was associated with hepatic injury of the nontumorous liver and whether such injury, if present,
was associated with increased morbidity or mortality after hepatic resection. Two-hundred and twelve eligible patients who
underwent hepatic resection for colorectal liver metastases between January 1999 and December 2005 were identified. Data on
demographics, clinicopathologic characteristics, and preoperative chemotherapy details were collected and analyzed. The majority
of patients received preoperative chemotherapy (n = 153; 72.2%). Chemotherapy consisted of fluoropyrimidine-based regimens: 5-FU monotherapy, 31.6%; irinotecan, 25.9%; and
oxaliplatin, 14.6%. Among those patients who received chemotherapy, the type of chemotherapy regimen predicted distinct patterns
of liver injury. Oxaliplatin was associated with increased likelihood of grade 3 sinusoidal dilatation (p = 0.017). Steatosis >30% was associated with irinotecan (27.3%) compared with no chemotherapy, 5-FU monotherapy, and oxaliplatin
(all p < 0.05). Irinotecan also was associated with steatohepatitis, as two of the three patients with steatohepatitis had received
irinotecan preoperatively. Overall, the perioperative complication rate was similar between the no-chemotherapy group (30.5%)
and the chemotherapy group (35.3%) (p = 0.79). Preoperative chemotherapy was also not associated with 60-day mortality. In patients with hepatic colorectal metastases,
preoperative chemotherapy is associated with hepatic injury in about 20 to 30% of patients. Furthermore, the type of hepatic
injury after preoperative chemotherapy was regimen-specific.
Presented at the American Hepato-Pancreato-Biliary Association 2006 Annual Meeting, March 11, Miami, Florida. 相似文献
42.
43.
Objective To investigate the best way to control the blood sugar level during the perioperation of bone fracture patients with type 2 diabetes(T2DM).Methods Bone fracture patients with T2DM were randomly divided into three groups:continuous subcutaneous insulin infusion group(insulin aspart,group CSII,n=20),glargine treatment group(insulin aspart+insulin glargine,group GA,n=20),and NPH treatment(insulin aspart+rh-insulin,group NA,n=20).The levels of fasting plasma glucose(FPG)and the 2 hours postprandial glucose(2h PG),blood glucose fluctuation(BGF),insulin dosage(ID),good effective time(GET),incidence of hypoglycemia,dawn phenomenon and infection,average time of stitches removal(ATSR),average hospitalized length(AHL)of three groups were compared.Results FPG and 2hPG,ID in group CSII[(6.32±1.18)mmol/L,(7.72±1.53)mmol/L,(35.40±1.60)IU]and group GA [(6.25±0.88)mmol/L,(7.32±1.17)mmol/L,(36.20±0.80)IU]were significantly lower than those of group NA [(7.44±1.36)mmol/L,(8.52±0.76)mmol/L,(40.50±2.40)IU,all P<0.05],simulaneously,BGF,GET incidence of complications,ATSR,AHL of group CSII and GA were significantly lower than those of group NA(all P<0.05).There were not significant difference between group CSII and group GA.Compared with group CSII,group GA had less costs in-hospital and better practicability.Conclusion Both CSII and insulin glargine combined with insulin aspart can effectively,safely,rapidly and stablely control hyperglycemia.and might be the first choice to control blood sugar for bone fracture patients with T2DM in perioperation. 相似文献
44.
腹腔镜肝右后叶囊肿开窗引流术35例报告 总被引:6,自引:1,他引:5
目的:探讨肝右后叶肝囊肿的腹腔镜处理方法。方法:1998年1月~2005年12月对35例有症状的肝右后叶囊肿(21例主要位于Ⅵ段,14例主要位于第Ⅶ段)采用四孔法行囊肿开窗引流术。囊肿位于肝右后叶上段者采用肝上入路,胆囊牵引钳或三叶钳推压肝脏使其向前向下,暴露肝后囊肿,囊肿开窗,修剪带蒂大网膜放入囊肿。囊肿位于肝右后叶下段者采用肝下入路,超声刀切开肝结肠韧带,右三角韧带及肝肾间疏松组织,胆囊牵引钳抬起肝脏,囊肿开窗,大网膜放入囊腔引流。结果:35例肝右后叶肝囊肿均在腹腔镜下完成肝囊肿开窗引流术,无中转开腹手术。15例采用肝上入路,20例采用肝下入路。手术时间30~95min,平均46min。无手术并发症。35例病理检查结果均为先天性肝囊肿。术后症状均消失。术后住院2~5d,平均3.8d。35例随访6~36个月,平均34个月,33例无复发,2例(为肝上入路病例)囊肿未完全消失,但较术前明显缩小,无明显症状,观察半年未见增大。结论:肝下及肝上入路囊肿开窗引流是腹腔镜下处理肝右叶肝囊肿的有效方法。 相似文献
45.
Nishida Koyo Mihara Kiyoshi Takino Toichi Nakane Sachi Takakura Yoshinobu Hashida Mitsuru Sezaki Hitoshi 《Pharmaceutical research》1991,8(4):437-444
The effect of electric charge on the hepatic disposition of macromolecules was studied in the rat. Charged derivatives of dextran (T-70) and bovine serum albumin (BSA), mitomycin C–dextran conjugates (MMC-D), and lactosaminated BSA (Lac-BSA) were employed as model macromolecules. After intravenous injection, cationic macromolecules were rapidly eliminated from plasma because of their extensive hepatic uptake, while anionic and neutral macromolecules were slowly eliminated. Cationic macromolecules were recovered from parenchymal and nonparenchymal hepatic cells at a cellular uptake (per unit cell number) ratio of 1.4–3.2, while that of Lac-BSA was 14. During liver perfusion using a single-pass constant infusion mode, cationic macromolecules were continuously extracted by the liver, with extraction ratios at steady-state (E
ss) ranging between 0.03 and 0.54, whereas anionic and neutral macromolecules were almost completely recovered in the outflow at steady state. The E
ss for cationized BSA (Cat-BSA) and cationic MMC-Dcat were concentration dependent and decreased at low temperatures and in the presence of colchicine and cytochalasin B. The possible participation of the internalization process in the uptake of cationic macromolecules by hepatocytes was suggested. 相似文献
46.
Kimberly A. Varker Edward W. Martin Dori Klemanski Bryan Palmer Manisha H. Shah Mark Bloomston 《Journal of gastrointestinal surgery》2007,11(12):1680-1685
Background
Transarterial chemoemobolization (TACE) is commonly used to treat metastatic carcinoid tumors; however, the management of
progressive disease is less clear. We sought to determine if patients with disease progression after TACE would benefit from
repeat TACE.
Methods
The records of 27 patients undergoing repeat TACE for radiologic or symptomatic progression after TACE for metastatic carcinoid
were reviewed and compared to 122 undergoing first TACE. Overall and progression-free survivals were estimated by the Kaplan–Meier
method.
Results
Mean disease-free interval after first TACE was 11.8 months. Radiologic response was observed in 61% compared to 82% after
first TACE (p = 0.058); hormone response in 64% compared to 80% (p = 0.159); and symptomatic response in 77% compared to 92% (p = 0.053). The complication rate after repeat TACE was lower than after first TACE (p = 0.03). Median overall survival was similar after repeat (28.1 months) and first TACE (33.3 months) (p = 0.53). Progression-free survival was shorter after repeat TACE but not significantly so. No factor examined could predict
survival after repeat TACE.
Conclusion
Repeat TACE for patients with hepatic carcinoid metastases failing first TACE or having evidence of disease progression is
safe and offers a viable treatment option.
Presented at the 48th Annual Meeting of The Society for Surgery of the Alimentary Tract, Washington, DC, May, 2007. 相似文献
47.
肝动脉解剖变异在肝癌介入治疗中的临床意义 总被引:1,自引:0,他引:1
目的探讨肝动脉解剖变异的DSA表现及其在肝癌肝动脉栓塞化疗(TACE)中的临床意义。方法回顾分析223例肝癌患者的DSA资料,对存在解剖变异的肝动脉进一步分析其起源、走行、分布及对TACE的影响,统计每组变异肝动脉的发生率。结果223例中,32例存在肝动脉解剖变异,占14.34%,共40支变异肝动脉,其中变异肝总动脉2支(5%,2/40),变异肝固有动脉1支(2.5%,I/40),变异肝右动脉24支(60%,24/40),变异肝左动脉13支(32.5,13/40),有30支变异肝动脉直接参与肿瘤供血,其中24支行TACE治疗,6支行肝动脉化疗(TAI)。结论正确认识肝动脉的解剖变异特征对提高TACE的成功率、降低手术风险有极其重要的意义。 相似文献
48.
Treatment strategy for synchronous metastases of colorectal cancer: is hepatic resection after an observation interval appropriate? 总被引:1,自引:1,他引:0
Yasuhiro Shimizu Kenzo Yasui Tsuyoshi Sano Takashi Hirai Yukihide Kanemitsu Koji Komori Tomoyuki Kato 《Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie》2007,392(5):535-538
Background In cases of synchronous colorectal hepatic metastases, the primary colorectal cancer strongly influences on the metastases.
Our treatment policy has been to conduct hepatic resection for the metastases at an interval of 3 months after colorectal
resection. We examined the appropriateness of interval hepatic resection for synchronous hepatic metastasis.
Materials and methods The subjects were 164 patients who underwent resection of hepatic metastasis of colorectal cancer (synchronous, 70 patients;
metachronous, 94 patients). Background factors for hepatic metastasis and postoperative results were compared for synchronous
and metachronous cases.
Results The cumulative survival rate for 164 patients at 3, 5, and 10 years postoperatively was 71.9%, 51.8%, and 36.6%, and the post-resection
recurrence rate in remnant livers was 26.8%. Interval resection for synchronous hepatic metastases was conducted in 49 cases
after a mean interval of 131 days. No difference was seen in postoperative outcome between synchronous and metachronous cases.
Conclusion The outcome was similarly favorable in cases of synchronous hepatic metastasis and in cases of metachronous metastasis. Delaying
resection allows accurate understanding of the number and location of hepatic metastases, and is beneficial in determining
candidates for surgery and in selecting surgical procedure. 相似文献
49.
无名异冲剂促进去卵巢大鼠骨质疏松性骨折愈合的机制研究 总被引:1,自引:0,他引:1
为探讨无名异冲剂促进去卵巢 SD大鼠骨质疏松性骨折愈合的机制 ,用 48只 6月龄雄性 SD大鼠建立骨质疏松性骨折模型 ,随机分为模型组、跳骨片组、仙灵骨葆组、无名异冲剂组 ,于灌胃后 2周、4周取材 ,观察 X线片、骨密度、光镜 ,骨痂钙、磷、胶原含量 ,结果显示灌胃第 2周时 ,各组动物各项指标均无显著性差异 ;第4周时 ,无名异冲剂组的骨密度 ,骨痂钙、磷、胶原含量的检测结果与模型组有显著性差异 ( P<0 .0 5 ) ,X线及光镜观察骨痂的生长情况 ,无名异冲剂组也优于模型组 ,说明无名异冲剂能够通过提高骨密度 ,改善骨骼钙、磷、胶原的代谢 ,促进骨折端骨痂的生长 ,达到治疗骨质疏松性骨折的目的。 相似文献
50.
目的探讨介入疗法在急性肢体动脉闭塞治疗中的应用价值。方法回顾性总结28例急性肢体动脉闭塞介入治疗经验。采用经皮血管腔内成形术和动脉内溶栓术治疗上肢动脉闭塞5例、腹主动脉下段闭塞1例、下肢动脉闭塞22例。结果经术后4个月~9年临床观察,急性单段动脉闭塞血管再通率为100%(8/8例)、多段动脉闭塞血管再通率为80%(16/20例),总血管再通率为85.71%(24/28例)。结论介入疗法是治疗急性肢体动脉闭塞的一种有效方法,值得推广应用。 相似文献